RS Bio ApS: Financial statements 2020
CVR: 39970899
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
RS Bio ApS (CVR 39970899) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -255,450 and a net result of DKK -162,621,984 compared with DKK -131,299,387 the year before. Equity in the 2020 report amounted to DKK 209,469,850. The solvency ratio was 99.8%.
- Gross Profit
- DKK -255,450
- Profit/Loss
- DKK -162,621,984
- Equity
- DKK 209,469,850
- Total Assets
- DKK 209,834,415
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -255 t. | -162.6 mio. | 209.5 mio. | 0 |
| 2019 | - | -234 t. | -131.3 mio. | 337.1 mio. | 0 |
Official annual report
How creditworthy is RS Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
RS Bio ApS has published its annual report for 2019. Gross profit came to DKK -234,278, and the net result was DKK -131,299,387.
About RS Bio ApS
RS Bio ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Renè Sindlev. The company is owned by RS GROUP ApS and RS2 Holdings ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -93,834 and a net result of DKK 18,815,451 compared with DKK 33,373,796 the year before. Equity in the 2025 report amounted to DKK 439,671,207.